Comparison of standard prophylactic and preemptive therapeutic low molecular weight heparin treatments in hospitalized patients with COVID-19

Copur, B; Surme, S; Sayili, UĞURCAN; Tuncer, G; Zerdali, E; Yazla, M; Nakir, I; Buyukyazgan, A; Kurt-Cinar, A; Balli, H; Kurekci, Y; Pehlivanoglu, F; Sengoz, G

doi:10.4149/bll_2021_100

Comparison of standard prophylactic and preemptive therapeutic low molecular weight heparin treatments in hospitalized patients with COVID-19

Copur B., Surme S., Sayili U., Tuncer G., Zerdali E., Yazla M., ...Daha Fazla

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.122, sa.9, ss.626-630, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 122 Sayı: 9
Basım Tarihi: 2021
Doi Numarası: 10.4149/bll_2021_100
Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
Sayfa Sayıları: ss.626-630
Anahtar Kelimeler: anticoagulant therapy, COVID-19, Low-molecular-weight heparin (LMWH), mortality, outcome, CORONAVIRUS DISEASE 2019, ANTICOAGULATION
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

INTRODUCTION: Anticoagulant treatment approach in patients with COVID-19 is not well studied and not standardized. We aimed to compare the effects of standard prophylactic and pre-emptive therapeutic Low-Molecular-weight Heparin (LMWH) treatment approaches on mortality in patients with COVID-19.